
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Sophie Viaud, Fabiana Saccheri, Grégoire Mignot, et al.
Science (2013) Vol. 342, Iss. 6161, pp. 971-976
Open Access | Times Cited: 1776
Sophie Viaud, Fabiana Saccheri, Grégoire Mignot, et al.
Science (2013) Vol. 342, Iss. 6161, pp. 971-976
Open Access | Times Cited: 1776
Showing 1-25 of 1776 citing articles:
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa, et al.
Science (2017) Vol. 359, Iss. 6371, pp. 91-97
Closed Access | Times Cited: 4408
Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa, et al.
Science (2017) Vol. 359, Iss. 6371, pp. 91-97
Closed Access | Times Cited: 4408
Role of the Microbiota in Immunity and Inflammation
Yasmine Belkaid, Timothy W. Hand
Cell (2014) Vol. 157, Iss. 1, pp. 121-141
Open Access | Times Cited: 4380
Yasmine Belkaid, Timothy W. Hand
Cell (2014) Vol. 157, Iss. 1, pp. 121-141
Open Access | Times Cited: 4380
Elements of cancer immunity and the cancer–immune set point
Daniel S. Chen, Ira Mellman
Nature (2017) Vol. 541, Iss. 7637, pp. 321-330
Closed Access | Times Cited: 4297
Daniel S. Chen, Ira Mellman
Nature (2017) Vol. 541, Iss. 7637, pp. 321-330
Closed Access | Times Cited: 4297
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
Vancheswaran Gopalakrishnan, Christine N. Spencer, Luigi Nezi, et al.
Science (2017) Vol. 359, Iss. 6371, pp. 97-103
Open Access | Times Cited: 3812
Vancheswaran Gopalakrishnan, Christine N. Spencer, Luigi Nezi, et al.
Science (2017) Vol. 359, Iss. 6371, pp. 97-103
Open Access | Times Cited: 3812
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani, Federica Marchesi, Alberto Malesci, et al.
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 7, pp. 399-416
Open Access | Times Cited: 3243
Alberto Mantovani, Federica Marchesi, Alberto Malesci, et al.
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 7, pp. 399-416
Open Access | Times Cited: 3243
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Ayelet Sivan, Leticia Corrales, Nathaniel Hubert, et al.
Science (2015) Vol. 350, Iss. 6264, pp. 1084-1089
Open Access | Times Cited: 3163
Ayelet Sivan, Leticia Corrales, Nathaniel Hubert, et al.
Science (2015) Vol. 350, Iss. 6264, pp. 1084-1089
Open Access | Times Cited: 3163
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vétizou, Jonathan M. Pitt, Romain Daillère, et al.
Science (2015) Vol. 350, Iss. 6264, pp. 1079-1084
Open Access | Times Cited: 2972
Marie Vétizou, Jonathan M. Pitt, Romain Daillère, et al.
Science (2015) Vol. 350, Iss. 6264, pp. 1079-1084
Open Access | Times Cited: 2972
The Human Intestinal Microbiome in Health and Disease
Susan V. Lynch, Oluf Pedersen
New England Journal of Medicine (2016) Vol. 375, Iss. 24, pp. 2369-2379
Closed Access | Times Cited: 2957
Susan V. Lynch, Oluf Pedersen
New England Journal of Medicine (2016) Vol. 375, Iss. 24, pp. 2369-2379
Closed Access | Times Cited: 2957
Interaction between microbiota and immunity in health and disease
Danping Zheng, Timur Liwinski, Eran Elinav
Cell Research (2020) Vol. 30, Iss. 6, pp. 492-506
Open Access | Times Cited: 2723
Danping Zheng, Timur Liwinski, Eran Elinav
Cell Research (2020) Vol. 30, Iss. 6, pp. 492-506
Open Access | Times Cited: 2723
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jérôme Galon, Daniela Bruni
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 3, pp. 197-218
Closed Access | Times Cited: 2614
Jérôme Galon, Daniela Bruni
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 3, pp. 197-218
Closed Access | Times Cited: 2614
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou, Jedd D. Wolchok, Lieping Chen
Science Translational Medicine (2016) Vol. 8, Iss. 328
Open Access | Times Cited: 2122
Weiping Zou, Jedd D. Wolchok, Lieping Chen
Science Translational Medicine (2016) Vol. 8, Iss. 328
Open Access | Times Cited: 2122
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman, Laurence Zitvogel, Catheriné Sautès-Fridman, et al.
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 12, pp. 717-734
Closed Access | Times Cited: 1882
Wolf H. Fridman, Laurence Zitvogel, Catheriné Sautès-Fridman, et al.
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 12, pp. 717-734
Closed Access | Times Cited: 1882
Cancer-related inflammation and treatment effectiveness
Connie I. Diakos, Kellie A. Charles, Donald C. McMillan, et al.
The Lancet Oncology (2014) Vol. 15, Iss. 11, pp. e493-e503
Closed Access | Times Cited: 1838
Connie I. Diakos, Kellie A. Charles, Donald C. McMillan, et al.
The Lancet Oncology (2014) Vol. 15, Iss. 11, pp. e493-e503
Closed Access | Times Cited: 1838
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
Ta-Chung Yu, Fangfang Guo, Yanan Yu, et al.
Cell (2017) Vol. 170, Iss. 3, pp. 548-563.e16
Open Access | Times Cited: 1678
Ta-Chung Yu, Fangfang Guo, Yanan Yu, et al.
Cell (2017) Vol. 170, Iss. 3, pp. 548-563.e16
Open Access | Times Cited: 1678
The human tumor microbiome is composed of tumor type–specific intracellular bacteria
Deborah Nejman, Ilana Livyatan, Garold Fuks, et al.
Science (2020) Vol. 368, Iss. 6494, pp. 973-980
Open Access | Times Cited: 1598
Deborah Nejman, Ilana Livyatan, Garold Fuks, et al.
Science (2020) Vol. 368, Iss. 6494, pp. 973-980
Open Access | Times Cited: 1598
The microbiota in adaptive immune homeostasis and disease
Kenya Honda, Dan R. Littman
Nature (2016) Vol. 535, Iss. 7610, pp. 75-84
Closed Access | Times Cited: 1594
Kenya Honda, Dan R. Littman
Nature (2016) Vol. 535, Iss. 7610, pp. 75-84
Closed Access | Times Cited: 1594
Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O’Donnell, Michele W.L. Teng, Mark J. Smyth
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 3, pp. 151-167
Closed Access | Times Cited: 1423
Jake S. O’Donnell, Michele W.L. Teng, Mark J. Smyth
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 3, pp. 151-167
Closed Access | Times Cited: 1423
Dysbiosis and the immune system
Maayan Levy, Aleksandra A. Kolodziejczyk, Christoph A. Thaiss, et al.
Nature reviews. Immunology (2017) Vol. 17, Iss. 4, pp. 219-232
Closed Access | Times Cited: 1385
Maayan Levy, Aleksandra A. Kolodziejczyk, Christoph A. Thaiss, et al.
Nature reviews. Immunology (2017) Vol. 17, Iss. 4, pp. 219-232
Closed Access | Times Cited: 1385
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp, et al.
Cancer Cell (2015) Vol. 28, Iss. 6, pp. 690-714
Open Access | Times Cited: 1351
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp, et al.
Cancer Cell (2015) Vol. 28, Iss. 6, pp. 690-714
Open Access | Times Cited: 1351
Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease
Joseph M. Pickard, Melody Y. Zeng, Roberta Caruso, et al.
Immunological Reviews (2017) Vol. 279, Iss. 1, pp. 70-89
Open Access | Times Cited: 1335
Joseph M. Pickard, Melody Y. Zeng, Roberta Caruso, et al.
Immunological Reviews (2017) Vol. 279, Iss. 1, pp. 70-89
Open Access | Times Cited: 1335
Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor
Veit Rothhammer, Iván Mascanfroni, Lukas Bunse, et al.
Nature Medicine (2016) Vol. 22, Iss. 6, pp. 586-597
Open Access | Times Cited: 1212
Veit Rothhammer, Iván Mascanfroni, Lukas Bunse, et al.
Nature Medicine (2016) Vol. 22, Iss. 6, pp. 586-597
Open Access | Times Cited: 1212
Gut microbiome development along the colorectal adenoma–carcinoma sequence
Qiang Feng, Suisha Liang, Huijue Jia, et al.
Nature Communications (2015) Vol. 6, Iss. 1
Open Access | Times Cited: 1196
Qiang Feng, Suisha Liang, Huijue Jia, et al.
Nature Communications (2015) Vol. 6, Iss. 1
Open Access | Times Cited: 1196
Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
Chi Ma, Miaojun Han, Bernd Heinrich, et al.
Science (2018) Vol. 360, Iss. 6391
Open Access | Times Cited: 1164
Chi Ma, Miaojun Han, Bernd Heinrich, et al.
Science (2018) Vol. 360, Iss. 6391
Open Access | Times Cited: 1164
The gut–liver axis and the intersection with the microbiome
Anupriya Tripathi, Justine W. Debelius, David A. Brenner, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 7, pp. 397-411
Open Access | Times Cited: 1115
Anupriya Tripathi, Justine W. Debelius, David A. Brenner, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 7, pp. 397-411
Open Access | Times Cited: 1115
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
Vancheswaran Gopalakrishnan, Beth A. Helmink, Christine N. Spencer, et al.
Cancer Cell (2018) Vol. 33, Iss. 4, pp. 570-580
Open Access | Times Cited: 1097
Vancheswaran Gopalakrishnan, Beth A. Helmink, Christine N. Spencer, et al.
Cancer Cell (2018) Vol. 33, Iss. 4, pp. 570-580
Open Access | Times Cited: 1097